Xin Lu

3.4k total citations · 1 hit paper
116 papers, 2.4k citations indexed

About

Xin Lu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xin Lu has authored 116 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Xin Lu's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (11 papers). Xin Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (11 papers). Xin Lu collaborates with scholars based in China, United States and United Kingdom. Xin Lu's co-authors include Xinting Sang, Yilei Mao, Huayu Yang, Haitao Zhao, Shouxian Zhong, Jinhong Duan, Xian‐Da Yang, Yiyao Xu, Hongbing Zhang and Jiefu Huang and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

In The Last Decade

Xin Lu

110 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis

2023 92 citations Shitao Jiang, Y. Liu et al. International Journal of Surgery profile →

Peers

Countries citing papers authored by Xin Lu

Since Specialization

Citations

This map shows the geographic impact of Xin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lu more than expected).

Fields of papers citing papers by Xin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lu. The network helps show where Xin Lu may publish in the future.

Co-authorship network of co-authors of Xin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lu. A scholar is included among the top collaborators of Xin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lu. Xin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trackable Radioactive ¹⁷⁷Lu-Microspheres Induce Immunogenic Cell Death by Transarterial Radioembolization Therapy in Hepatocellular Carcinoma 2025 ·ACS Materials Letters ·(unknown), Xin Lu, (unknown), (unknown), Simin He, Xiaoping Xu, Jianping Zhang, Shaoli Song	2
2	Causal association of cholesterol metabolism-related proteins with hepatocellular carcinoma and dysfunction-associated steatotic liver disease: a mendelian randomization study 2025 ·Discover Oncology ·(unknown), Shitao Jiang, Y. Liu, Han Zheng, Lei Zhang, (unknown), Xin Lu	0
3	Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma 2024 ·Journal of Controlled Release ·(unknown), (unknown), Xin Lu, Mingzhen Xu, Simin He, Jianping Zhang, Shaoli Song	1
4	Establishment and evaluation of animal models of sepsis-associated encephalopathy 2023 ·World Journal of Emergency Medicine ·(unknown), Yanxia Gao, Shigong Guo, Xin Lu, (unknown), (unknown), Huadong Zhu, Yi Li	9
5	Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis breakdown → 2023 ·International Journal of Surgery ·Shitao Jiang, Y. Liu, Han Zheng, Lei Zhang, Haitao Zhao, Xinting Sang, Yiyao Xu, Xin Lu	92
6	The association between levosimendan and mortality in patients with sepsis or septic shock: a systematic review and meta-analysis 2023 ·European Journal of Emergency Medicine ·(unknown), Yanxia Gao, Xin Lu, (unknown), (unknown), (unknown), Joseph Harold Walline, Huadong Zhu, Yi Li	4
7	A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study 2021 ·Neuroendocrinology ·Gang Xu, Yao Xiao, (unknown), Bao Jin, (unknown), Xueshuai Wan, Yongchang Zheng, Haifeng Xu, Xin Lu, Xinting Sang, Penglei Ge, Yilei Mao, Jianqiang Cai, Hong Zhao, Shunda Du	7
8	Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma 2021 ·Frontiers in Immunology ·Jianzhen Lin, Songhui Zhao, Dongxu Wang, Yang Song, (unknown), Yang Xu, Jinzhu Mao, Fucun Xie, Junyu Long, Yi Bai, Xiaobo Yang, Lei Zhang, Jin‐Song Bian, Xin Lu, Xinting Sang, Jie Pan, Kai Wang, Haitao Zhao	6
9	Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma 2021 ·Annals of Translational Medicine ·Jin‐Song Bian, Junyu Long, Xu Yang, Xiaobo Yang, Yiyao Xu, Xin Lu, Mei Guan, Xinting Sang, Haitao Zhao	7
10	EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis 2020 ·Journal of Autoimmunity ·Xinyue Xiao, Yueting Li, Xu Jiang, Xin Ji, Xin Lu, Bo Yang, Lijun Wu, Xiaohan Wang, (unknown), Lidan Zhao, Yun-yun Fei, Huaxia Yang, Wen Zhang, Fengchun Zhang, Fu-lin Tang, Jianmin Zhang, Wei He, Hua Chen, Xuan Zhang	51
11	Efficacy and safety of corticosteroids for septic shock in immunocompromised patients: A cohort study from MIMIC 2020 ·The American Journal of Emergency Medicine ·Xin Lu, Xue Wang, Yanxia Gao, (unknown), Lina Zhao, Zhongheng Zhang, Huadong Zhu, Yi Li	16
12	SAMD9 is a (epi-) genetically regulated anti-inflammatory factor activated in RA patients 2019 ·Molecular and Cellular Biochemistry ·Pei He, Long‐Fei Wu, (unknown), Wei Xia, Lan Wang, (unknown), Xin Lu, Shu‐Feng Lei, Fei‐Yan Deng	14
13	Efficacy of initial haemopurification strategy for acute paraquat poisoning in adults: study protocol for a randomised controlled trial (HeSAPP) 2018 ·BMJ Open ·Jianwei Cui, Yinyan Xu, Yibo Wang, Yanxia Gao, Shigong Guo, Meng Wang, Xin Lu, (unknown), Yong Ma, Ding Yuan, Lu Che, (unknown), Xuezhong Yu, Huadong Zhu, Yi Li	5
14	Efficacy and outcomes of lipid resuscitation on organophosphate poisoning patients: A systematic review and meta-analysis 2018 ·The American Journal of Emergency Medicine ·(unknown), Shanshan Yu, Lili Zhang, Yanxia Gao, Joseph Harold Walline, Xin Lu, (unknown), Huadong Zhu, Xuezhong Yu, Yi Li	9
15	The distribution and functional relevance analysis of runs of homozygosity (ROHs) in Chinese Han female population 2017 ·Molecular Genetics and Genomics ·Yihua Lu, (unknown), Wei Xia, Xingbo Mo, Long‐Fei Wu, Xiaowei Zhu, Pei He, (unknown), Xin Lu, Fei‐Yan Deng, Shu‐Feng Lei	2
16	Selection of a novel DNA thioaptamer against HER2 structure 2015 ·Clinical & Translational Oncology ·Yan Hu, Junwen Duan, Bangrong Cao, L. Zhang, Xin Lu, (unknown), (unknown), Zhaohui Zhu, Wei Yuan, (unknown), (unknown)	20
17	Integrated Analyses of Gene Expression Profiles Digs out Common Markers for Rheumatic Diseases 2015 ·PLoS ONE ·Lan Wang, Long‐Fei Wu, Xin Lu, Xingbo Mo, Zaixiang Tang, Shu‐Feng Lei, Fei‐Yan Deng	18
18	Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma 2015 ·Medicine ·Wenjun Liao, (unknown), Penglei Ge, Huayu Yang, (unknown), Xin Lu, Xinting Sang, Shouxian Zhong	55
19	Spontaneous rupture of a giant hepatobiliary serous cystadenoma: report of a case and literature review 2010 ·Hepatology International ·Yongliang Sun, Xin Lu, Yiyao Xu, Yilei Mao, Zhiying Yang, Xinting Sang, Shouxian Zhong, Jiefu Huang	4
20	A novel method of pyloric occlusion in the treatment of blunt retroperitoneal duodenal injuries (BRDI) with delayed diagnosis 2009 ·Injury Extra ·Zhiying Yang, Tianyi Chi, Xin Lu, Xinting Sang, (unknown), Shouxian Zhong	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact